Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 3, 2008, Pages 445-449

  Taguchi, Akihiko ^a   Matsuyama, Tomohiro ^b   Nakagomi, Takayuki ^b   Shimizu, Yoko ^a   Fukunaga, Ryuzo ^c   Tatsumi, Yoshiaki ^b   Yoshikawa, Hiroo ^b   Kikuchi Taura, Akie ^d   Soma, Toshihiro ^d   Moriwaki, Hiroshi ^a   Nagatsuka, Kazuyuki ^a   Stern, David M ^e   Naritomi, Hiroaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c HOSHIGAOKA KOSEINENKIN HOSPITAL   (Japan)

^d MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antigens; CD34; Cerebral circulation; Cognitive impairment

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; STATIN; TICLOPIDINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CIRCULATION; CARDIOVASCULAR RISK; CD34 SELECTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTIGENS, CD34; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; RISK; SEVERITY OF ILLNESS INDEX;

EID: 39749152729     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600541     Document Type: Article

References (16)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th ed Washington, DC: American Psychiatric Association
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-7
3. Casserly I, Topol E (2004) Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139-46
4. Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne MH, Philip PJ (2007) Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol 254:327-32
5. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37:2277-82
6. Kikuchi-Taura A, Soma T, Matsuyama T, Stern DM, Taguchi A (2006) A new protocol for quantifying CD34+ cells in peripheral blood of patients with cardiovascular disease. Texas Heart Inst J 33:427-9
7. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ (2001) Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97:3075-85
8. Maler JM, Spitzer P, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J (2006) Decreased circulating CD34+ stem cells in early Alzheimer's disease: evidence for a deficient hematopoietic brain support? Mol Psychiatry 11:1113-5
9. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981-7
10. Shyu WC, Lin SZ, Chiang MF, Su CY, Li H (2006) Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 26:3444-53
11. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213-26
12. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H (2004a) Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109:2972-5
13. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T (2004b) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-8
14. Vagnucci Jr AH, Li WW (2003) Alzheimer's disease and angiogenesis. Lancet 361:605-8
15. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-7
16. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. New Engl J Med 353:999-1007